LifeArc and the Bill & Melinda Gates Foundation are jointly investing £6 million ($7.2m) in the Grand Challenges African Drug Discovery Accelerator (GC ADDA) programme, a collaboration that will support 5 African drug discovery projects over 3 to 5 years.

LifeArc, the medical research charity, and the University of St Andrews Infection Group today (August 7) announced a partnership to develop a molecular diagnostic test for the detection and quantification of tuberculosis (TB) bacteria in patients.